July 02, 2026 10:32 am (IST)

Make this your homepage

Health

Ram Mandir donation theft: Six accused were employed by Varanasi-based security firm, probe reveals | Ayodhya Ram Temple donation theft: Probe says majority of money was allegedly stolen during Kumbh Mela | Commercial LPG price slashed by Rs 183.50 from July 1; check new rates in Delhi, Mumbai, Kolkata and Chennai | Trump suffers major blow as US Supreme Court upholds birthright citizenship | Delhi-Mumbai Expressway horror: Passenger bus goes up in flames after fatal collision, 8 dead | 'Dharmendra Pradhan will be responsible if anything happens': CJP warns as Sonam Wangchuk's health worsens on day 3 of hunger strike | Adani Ports seals $1.4 billion mega deal as MSC buys 49% stake in Vizhinjam port | Ram Temple donation scam: Former trust chief Champat Rai grilled by SIT for 2 hours, says report | Brazil escape Japan scare, Germany crash out as Paraguay script World Cup shocker | India overtakes Taiwan, South Korea to become world's fifth-largest equity market again

Philippines healthcare providers administer vaccine approved for prevention of Dengue

India Blooms News Service | | Feb 23, 2016, at 05:00 am

Kolkata/Lyon, Feb 22 (IBNS): Sanofi Pasteur, the vaccines division of Sanofi, announced on Monday that vaccinations with Dengvaxia have commenced in the Philippines following official receipt of the first shipment of the vaccine earlier this month.

Dengvaxia, a tetravalent dengue vaccine, was approved in the Philippines on 22 December 2015 for the prevention of disease caused by all four Dengue types in individuals from 9-45 years of age living in endemic areas.

The vaccine is administered in three doses given over a one-year period. Asia bears 70% of dengue fever burden globally with an estimated 67 million people being sickened by the disease annually.

In the Philippines alone, over 110,000 people on average get Dengue every year. Asian endemic countries spend an estimated 6.5 billion USD annually in both direct medical and indirect costs due to Dengue.

“This is truly a great moment in the history of vaccinology,” states Guillaume Leroy, Vice-President of Dengue Vaccine, Sanofi Pasteur. “Dengvaxia’s availability for administration by healthcare providers in the Philippines, to be followed closely by the initiation of a public sector immunization program in the country is a landmark event for global Dengue prevention and a great achievement for the people of the Philippines.”

Medical Societies in the Philippines held a media event in Manila earlier this month to welcome receipt of the first shipment of Dengvaxia to the country.

In attendance, Dr. Rose Capeding, chief of the Research Institute for Tropical Medicine’s department of microbiology, noted that the Philippines participated in all three phases of the clinical development of the vaccine and that healthcare providers there were delighted to be able to begin vaccinating against dengue, which continues to pose a major public health threat to the nation.

#Philippines # healthcare # Vaccine # prevention of Dengue

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.

India
International

Related Images

CMRI Hospital celebrates Patients' Experience Week with Walkathon Oct 09, 2025, at 06:21 pm

Kolkata: BITM hosts an interactive session with students to observe Shubhanshu Shukla's return to Earth Jul 16, 2025, at 07:45 pm

West Bengal government airlifts ailing Gangasagar pilgrims to Kolkata Jan 13, 2025, at 12:45 pm